Solabia Group

Presentation


Present in the cosmetics, pharmacy, nutrition, biotechnology and microbiological diagnosis sectors, the Solabia Group, with its six production units, has complementary expertise that enables it to offer an extensive range of active principles and ingredients used throughout the world by the cosmetics, pharmaceutical and food industries.

In three decades, Solabia has become an international group, the result of perfectly controlled internal and external growth.

Our research and development centres group together more than thirty international calibre researchers whose original expertise – driver of innovation – enables us to completely master the techniques of biocatalysis, enzymatic synthesis, fermentation and plant extraction.  This complementary expertise enables us to create innovative products as well as partnerships with both our customers and internationally renowned research organisations.

By placing Corporate Social Responsibility (CSR) among its priorities, our group confirms its commitment to sustainable development. All the company’s resources are mobilised to respond to the economic, social and environmental challenges and build a more responsible future together.

A strategy focused on innovation, a strong investment policy and the mobilisation of all its teams allows the Solabia Group to achieve its objectives: meet the requirements of its customers and its various markets.









Activities


Cosmetics

Present in more than 30 countries, the Solabia Group's Cosmetics Division has been developing, manufacturing and marketing cosmetic active ingredients for finished product brands for more than 40 years, covering all segments of the industry, from Luxury, Beauty Salon, Masstige, Mass-market, etc.

Having a very varied range of ingredients due to its high Innovation potential combined, not only with the internationally recognised Expertise of its researchers, but also with its diverse technologies and the industrial control of its production units, in fields as varied as Biotechnology, Plant & Marine Extraction, Fine Chemicals and Encapsulation, our primary vocation is to meet the different needs of a constantly evolving market, whose requirements in terms of traceability, sourcing, naturalness, efficacy, safety and regulatory compliance are increasingly numerous, with the ultimate aim of enhancing the beauty of the skin and hair.


Pharmaceuticals & Nutraceuticals


To establish the Solabia groupas a preferred partner of the major pharmaceutical and nutraceutics firms, Solabia has enhanced the value of the nature’s resources, its areas of expertise, but also to the high quality standards of its production units answering the constraints of the pharmacopoeia, to propose successful products in consumer expectations for a nutrition and a modern food complementation.

The pharmacy and Nutritional division of Solabia, propose ranges of original ingredients recognized for their health benefits whether they are animal-derived, vegetal or marine or from biotechnological or fine chemistry.

The Solabia group is particularly attached to developing close working relationships with its customers. Ever in touch with their needs and requirements, our marketing and RD teams offer ready – to –use concepts to initiate new projects and advice on formulation to help them in the implementation and the positioning of our innovative assets.


BIOKAR Diagnostics

BIOKAR Diagnostics is the microbiology division of the Solabia group, dedicated to the development, production and selling of culture media, supplements and detection kits for microbiology laboratories.

BIOKAR Diagnostics offers more than 40 years of experience in microbiology, in sectors as varied as:
→ Agro food industries
→ Cosmetic industries
→ Pharmaceutical industries
→ Water and environmental
→ Animal health
→ Research institutions and education

With over 300 products and a presence in over 40 countries, BIOKAR Diagnostics has acquired an international reputation for the quality of his products and innovative solutions.

 

Peptones & Hydrolysates

Backed by nearly 40 years of experience, SOLABIA Biotech occupies a leading role in the peptone marketplace worldwide.  Our two manufacturing sites (France and Brazil) are certified ISO 9001 v. 2008 and allow all customers, regardless of market sector, total confidence as it pertains to  reliability, reproducibility and traceability. Solabia’s French production facility in particular is characterized by a closed system, Kosher certification and modern, computer controlled processes including best-in-class modern reactor design, which result in greater peptone consistency and improved attributes for clarity, stability and color. This production site alone underscores Solabia’s long-term commitment to the industry whose members prize above all vendor reliability and consistency.

Solabia’s unique added value sets it apart from other vendors in this industry. Our current catalogue offers a wide range of choices between animal, non-animal & casein hydrolysates. As such, we are uniquely positioned to respond to a vast array of requirements from varied sectors, including fermentation (lactic ferments, starters, probiotics), bio-pharmaceuticals (toxin and vaccine production), diagnostics (components of culture media), and more recently, cell culture. In light of the two production sites, high volume and occasional users are treated with the same ease. Risk mitigation and production redundancy for strategic products (i.e. Tryptone) address issues few in the industry can match. See how raising the standard can impact on your industrial process and you’ll agree that Modern Peptone Manufacturingmakes a difference.

 









Know how


Originally specialised in enzymatic hydrolysis, our Group rapidly expanded its activities and expertise through its various acquisitions and also through the development of new technologies within its production units.

The group’s expertise in biotechnology, fine chemistry, hydrolysis, enzymatic synthesis and extraction gives us a coherent set of technologies allowing it to respond to, as well as anticipate, the expectations of the various sectors on which it is present. 

Recently, the Solabia Group decided to complete its offer by capitalising on the wealth and diversity of algae through the acquisition of the Algues & Mer company based in Ouessant.









Organisation


Our Group has 6 production units at the forefront of technology to serve its various markets:  
- Beauvais site (France 60): fermentation, enzymatic hydrolysis, extraction, purification, grinding, mixing.
- Allonne site (France 60): manufacture and sterile distribution of microbiological diagnostic reagents.
- Anet site (France 28): fine chemistry, chemical and enzymatic synthesis, enzymatic hydrolysis, bioconversion.
- Meaux site (France 77): plant extraction.
- Ile d’Ouessant site (France 29): marine extraction.
- Brazilian sites (Maringa Parana): hydrolysis, plant extraction.

Our subsidiaries (Brazil, United States, Germany) and our network of distributors coordinated by our teams, enable us to ensure the same quality of service on the 5 continents.